T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.57% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.16% |
| 4 | Industrials | 12.02% |
| 5 | Technology | 10.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Warner Bros
WBD
$69.6B
| $7.34M | ﹤0.01% |
238,530
-24,010
| -9% | -$753K |
|
1402
Urban Outfitters
URBN
$6.65B
| $7.33M | ﹤0.01% |
160,670
+5,390
| +3% | +$210K |
|
|
PATI
1403
DELISTED
Patriot Transportation Holding, Inc. Common Stock
PATI
| $7.28M | ﹤0.01% |
+291,609
| New | +$6.98M |
|
|
WFC.WS
1404
DELISTED
Wells Fargo & Company Ws
WFC.WS
| $7.28M | ﹤0.01% |
355,275
| – | – |
|
1405
Xencor
XNCR
$1.7B
| $7.24M | ﹤0.01% |
+472,429
| New | +$7.46M |
|
|
FLIR
1406
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $7.2M | ﹤0.01% |
230,090
+16,080
| +8% | +$507K |
|
|
AFFX
1407
DELISTED
Affymetrix Inc
AFFX
| $7.17M | ﹤0.01% |
570,900
+539,200
| +1,701% | +$6.26M |
|
|
AENZ
1408
DELISTED
Aenza S.A.A.
AENZ
| $7.16M | ﹤0.01% |
316,227
-17,840
| -5% | -$515K |
|
|
PDCO
1409
DELISTED
Patterson Companies, Inc.
PDCO
| $7.09M | ﹤0.01% |
145,270
-7,354
| -5% | -$367K |
|
1410
Enerpac Tool Group
EPAC
$1.88B
| $7.07M | ﹤0.01% |
297,700
-28,000
| -9% | -$687K |
|
|
KYTH
1411
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $7.07M | ﹤0.01% |
140,892
-190,321
| -57% | -$7.99M |
|
1412
CorVel
CRVL
$3.31B
| $7.02M | ﹤0.01% |
612,198
-42,600
| -7% | -$497K |
|
1413
Bio-Rad Laboratories Class A
BIO
$9.56B
| $6.97M | ﹤0.01% |
51,590
+4,300
| +9% | +$533K |
|
1414
Grupo Cibest SA
CIB
$22.7B
| $6.91M | ﹤0.01% |
175,750
+6,150
| +4% | +$265K |
|
|
HABT
1415
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
| $6.88M | ﹤0.01% |
214,100
-13,000
| -6% | -$411K |
|
1416
Copart
CPRT
$29.2B
| $6.82M | ﹤0.01% |
1,452,800
-40,800
| -3% | -$189K |
|
|
FOLD
1417
DELISTED
Amicus Therapeutics
FOLD
| $6.76M | ﹤0.01% |
+621,249
| New | +$5.48M |
|
1418
O-I Glass
OI
$1.03B
| $6.74M | ﹤0.01% |
288,820
-5,010
| -2% | -$123K |
|
1419
iShares MSCI India ETF
INDA
$6.55B
| $6.72M | ﹤0.01% |
209,300
-385,400
| -65% | -$12.4M |
|
|
ZEN
1420
DELISTED
ZENDESK INC
ZEN
| $6.55M | ﹤0.01% |
+288,836
| New | +$6.91M |
|
|
NE
1421
DELISTED
Noble Corporation
NE
| $6.51M | ﹤0.01% |
456,150
+9,690
| +2% | +$157K |
|
|
NAUH
1422
DELISTED
National American University Holdings, Inc.
NAUH
| $6.48M | ﹤0.01% |
1,964,543
-60,000
| -3% | -$192K |
|
1423
Chemed
CHE
$7B
| $6.46M | ﹤0.01% |
54,100
+11,600
| +27% | +$1.29M |
|
1424
Hain Celestial
HAIN
$52.8M
| $6.41M | ﹤0.01% |
100,000
+70,300
| +237% | +$4.16M |
|
|
SRT
1425
DELISTED
Startek Inc.
SRT
| $6.38M | ﹤0.01% |
856,410
+31,680
| +4% | +$270K |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.